The platform controls the account and subscription layer (portal access and billing), while licensed clinicians control medical eligibility and prescribing
Patients should be advised to: Maintain adequate hydration (for most adults, around 6-8 drinks per day), adjusting for individual needs and comorbidities Seek specific advice from a healthcare professional if you have kidney disease or heart failure Avoid excessive alcohol consumption, particularly beer and spirits, which can raise uric acid levels Limit sugary drinks containing fructose, which has been linked to increased uric acid production [18] Dietary modifications can support uric acid management: Reduce intake of purine-rich foods such as red meat, organ meats, certain seafood (anchovies, sardines, mussels), and yeast extracts Increase consumption of low-fat dairy products , which may have a protective effect against gout [17] Some evidence suggests cherries or cherry juice may help reduce uric acid levels, though this should not replace medical therapy Maintain a balanced diet with plenty of vegetables and fruits Medication considerations should be discussed with a GP or specialist: Patients with recurrent gout may benefit from urate-lowering therapy (ULT), with allopurinol as the first-line treatment according to NICE guidance (NG219) Febuxostat may be considered if allopurinol is not tolerated or contraindicated, though the MHRA advises caution in patients with pre-existing major cardiovascular disease [13] [14] The target uric acid level for gout management is typically below 360 mol/L (or below 300 mol/L in severe gout or with tophi) [11] When starting or increasing ULT, flare prophylaxis with colchicine (500 micrograms once or twice daily) is typically recommended for up to 6 months Monitoring is essential
Signs of acute tennis elbow include pain that developed recently following increased activity, tenderness directly over the lateral epicondyle, pain that worsens with resisted wrist extension, and morning stiffness that improves with movement
Called Byetta, it had been approved by the FDA the previous year
